Cost-effectiveness of warfarin: Trial versus ‘real-life’ stroke prevention in atrial fibrillation

Background and purpose: Previous cost-effectiveness analyses analyzed warfarin for stroke prevention in randomized trial settings. Given the complexities of warfarin treatment, cost-effectiveness should be examined within a real-world setting.